A61P 29/02
Without antiinflammatory effect
Official title: without antiinflammatory effect
A61P29/02 (Without antiinflammatory effect) appears on 1,597 US grants and 2,512 published applications in this corpus.
Search patents in A61P- Granted patents
- 1,597
- Published applications
- 2,512
- Assignees
- 905
- Inventors
- 4,893
- Latest grant
- 12 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1980 | 1 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 2 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 1 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 5 | 0 |
| 1997 | 3 | 0 |
| 1998 | 7 | 0 |
| 1999 | 9 | 0 |
| 2000 | 20 | 0 |
| 2001 | 26 | 10 |
| 2002 | 33 | 51 |
| 2003 | 36 | 94 |
| 2004 | 30 | 106 |
| 2005 | 33 | 126 |
| 2006 | 44 | 139 |
| 2007 | 50 | 86 |
| 2008 | 63 | 138 |
| 2009 | 54 | 163 |
| 2010 | 93 | 140 |
| 2011 | 75 | 123 |
| 2012 | 99 | 93 |
| 2013 | 91 | 116 |
| 2014 | 109 | 101 |
| 2015 | 77 | 139 |
| 2016 | 94 | 121 |
| 2017 | 116 | 155 |
| 2018 | 85 | 106 |
| 2019 | 79 | 97 |
| 2020 | 54 | 89 |
| 2021 | 55 | 83 |
| 2022 | 36 | 56 |
| 2023 | 33 | 53 |
| 2024 | 43 | 50 |
| 2025 | 23 | 52 |
| 2026 | 16 | 25 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Therapeutic system for the topical, transdermal and transcutaneous application of carbon monoxide12 May 2026US 12,622,880 B2Julius-Maximilians-Universitaet Wuerzburg
- Substituted pyrazolo [1,5-a]pyrimidines having multimodal activity against pain5 May 2026US 12,617,797 B2Esteve Pharmaceuticals, S.A.
- Method for treating endometriosis-associated pain by using diaminopyrimidine compound21 Apr 2026US 12,605,381 B2Beijing Tide Pharmaceutical Co., Ltd.
- TRPV1 epitopes and antibodies31 Mar 2026US 12,590,147 B2Oblique Therapeutics AB
- Topical analgesic gel compositions24 Mar 2026US 12,582,615 B2Bayer HealthCare LLC
- Optogenetic modulation of central nervous system for treating pain10 Sep 2026US 2026/0263830 A1Opsin Biotherapeutics, Inc.
- Method of ameliorating inflammation of periodontal tissue13 Aug 2026US 2026/0232705 A1Institute of Rheological Function of Food Co., Ltd.
- Injectable formulation for pain reduction including beta-nicotinamide mononucleotide and method of preparing the same6 Aug 2026US 2026/0224473 A1
- Capsaicin emulsion composition, preparation method therefor, and use thereof30 Jul 2026US 2026/0216105 A1Nanjing Delova Biotech Co., Ltd.
- Composition comprising estetrol and drospirenone for use in relieving and treating pain30 Jul 2026US 2026/0216211 A1Eatetra Srl
Most cited
By later US patents
- Human antibodies that bind human TNF.alpha.451US 6,090,382 ABASF SE · 2000
- Human antibodies that bind human TNFα308US 6,258,562 B1BASF SE · 2001
- Method for reduction of migraine headache pain225US 5,714,468 A1998
- Human antibodies that bind human TNFa212US 6,509,015 B1BASF SE · 2003
- Antibody purification179US 7,863,426 B2Abbott Biotechnology Ltd. · 2011